Look for:

Our offer for

NOVO-NORDISK AS B


ISIN:
DK0060534915
WKN:
-

2023/01/26 16:59:51
Price
939.30 DKK
Difference -0.92% (-8.70)

General attributes

ISINDK0060534915
SymbolNOVO B
ExchangeNasdaq Copenhagen
CurrencyDKK
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)215,209 EUR
BenchmarkOMX COPENHAGEN 20

Market data

Bid (Bid size)940.40 DKK (65)
Ask (Ask size)940.70 DKK (102)
Open946.00 DKK
High952.40 DKK
Low937.10 DKK
Close (prev. day)948.00 DKK
VWAP943.381679 DKK
Volume (pcs)1,041,792
Trading volume982,804,123.30
Number of trades12,201
Last size1,000

Futures and Options

Related Futures12
Related Options-

PDF Downloads

Annual report: NOVO-NORDISK AS BPDF Download

Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Recent research



2023/01/26 16:59:51
Price
939.30 DKK
Difference -0.92% (-8.70)

General attributes

ISINDK0060534915
SymbolNOVO B
ExchangeNasdaq Copenhagen
CurrencyDKK
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)215,209 EUR
BenchmarkOMX COPENHAGEN 20

Market data

Bid (Bid size)940.40 DKK (65)
Ask (Ask size)940.70 DKK (102)
Open946.00 DKK
High952.40 DKK
Low937.10 DKK
Close (prev. day)948.00 DKK
VWAP943.381679 DKK
Volume (pcs)1,041,792
Trading volume982,804,123.30
Number of trades12,201
Last size1,000

Performance and Risk

6M1Y3Y
Perf (%)+9.15%+51.88%+127.60%
Perf (abs.)+10.58+43.10+70.74
Beta1.141.111.07
Volatility31.7032.0630.02
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Price data

Ø price 5 days | Ø volume 5 days (pcs.)955.20 DKK (1,141,257)
Ø price 30 days | Ø volume 30 days (pcs.)942.79 DKK (1,370,211)
Ø price 100 days | Ø volume 100 days (pcs.)855.24 DKK (1,548,223)
Ø price 250 days | Ø volume 250 days (pcs.)798.59 DKK (1,787,109)
YTD High | date976.30 DKK (2023/01/04)
YTD Low | date896.50 DKK (2023/01/12)
52 Weeks High | date976.30 DKK (2023/01/04)
52 Weeks Low | date607.60 DKK (2022/01/27)

All listings for NOVO-NORDISK AS B

Exchange  DateTimePriceTrading volume (mio.)Number of trades
Xetra2023/01/2617:35125.78 EUR1.11170
Vienna Stock Exchange2023/01/2617:32126.06 EUR0.013
Tradegate2023/01/2708:04125.72 EUR0.012
Stuttgart2023/01/2708:02125.72 EUR0.001
SIX Swiss Exchange2023/01/2417:36135.00 CHF0.001
Nasdaq Copenhagen2023/01/2616:59939.30 DKK982.8012,201
Munich2023/01/2708:00125.72 EUR0.001
London Stock Exchange European Trade Reporting2023/01/2616:55945.50 DKK1.2028
Hanover2023/01/2708:02125.54 EUR0.001
Hamburg2023/01/2708:02125.54 EUR0.001
Frankfurt2023/01/2708:00125.54 EUR0.001
FINRA other OTC Issues2023/01/2621:52139.00 USD0.4128
Duesseldorf2023/01/2708:10125.58 EUR0.001
Berlin2023/01/2708:04125.74 EUR0.001
BX Swiss2023/01/2618:00126.251 CHF0.154

Company Logo

https://gateway.mdgms.com/extern/logo_image.html?ID_LOGO=31640&ID_TYPE_IMAGE_LOGO=2

Contact Details

NOVO NORDISK A/S
- -
Novo Allé 1 - 2880 Bagsværd
Telefon: 45-44-44-88-88
Fax: -
E-mail: -

PDF Downloads

Annual report: NOVO-NORDISK AS BPDF Download

Company Profile

Novo Nordisk A/S is a global healthcare company, which engages in the the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Biopharm segments. The Diabetes and Obesity Care segment includes insulin, GLP-1 and related delivery systems, oral antidiabetic products (OAD), obesity, and other serious chronic diseases. The Biopharm segment focuses on rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1925 is headquartered in Bagsværd, Denmark.

Members of Management Board

Lars Fruergaard JørgensenChairman of Managing Board
Camilla SylvestMember of Executive Committee
Doug LangaMember of Executive Committee
Henrik WulffMember of Executive Committee
Karsten Munk KnudsenMember of Executive Committee
Ludovic HelfgottMember of Executive Committee
Marcus SchindlerMember of Executive Committee
Martin Horst LangeMember of Executive Committee
Maziar Mike DoustdarMember of Executive Committee
Monique CarterMember of Executive Committee

Board of directors

Helge LundChairman of Supervisory Board
Martin MacKayMember of Supervisory Board
Sylvie GrégoireMember of Supervisory Board
Andreas FibigMember of Supervisory Board
Elisabeth ChristensenMember of Supervisory Board
Henrik PoulsenMember of Supervisory Board
Jeppe Fonager ChristiansenMember of Supervisory Board
Kasim KutayMember of Supervisory Board
Laurence DebrouxMember of Supervisory Board
Liselotte HyveledMember of Supervisory Board
Mette Bøjer JensenMember of Supervisory Board
Thomas RantzauMember of Supervisory Board





Decline
Accept

We use cookies and web analysis software to give you the best possible experience on our website. If you consent, these tools will be used. For more details please read our Data protection policy.

INFORMATION FOR PRIVATE CLIENTS / CONSUMERS

Any information, material and services regarding financial instruments and securities provided by Erste Group Bank AG or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites”) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions (the “Interested Party“).

The publication and distribution of information as well as offering and selling of products and services described on the Websites is prohibited by law in some jurisdictions. For this reason, persons in countries in which the publication as well as the offering and selling of products and services described on the Websites are not permitted by law, must not enter the Websites and/or acquire the products displayed on the Websites.

Neither Erste Group nor any third party shall offer access to the Websites or offer the products to especially, but not limited to citizen/residents of the United States and “U.S. person” (as defined in Regulation S under the US Securities Act 1933 as amended). For this reason, the distribution or redistribution of the information, materials and products into United States or into any other jurisdiction where it is not permitted under the applicable law, as well as to the citizens/residents of these countries shall be prohibited. The securities displayed on the Websites have not been and will not be registered under the US Securities Act of 1933 and trading in the securities has not been approved for purposes of the US Commodities Exchange Act of 1936. For this reason the securities may, inter alia, not be offered, sold or delivered within the United States or, for the account and benefit of U.S. persons.

The Interested Party is solely responsible to examine, whether he may enter the Websites under the law applicable to it. Erste Group shall not be responsible for the distribution of content of any of the Websites to individuals or entities which provide false information about their right to enter the Websites. For this reason Erste Group shall not be liable for any legal claims or damages which may result from the unauthorized entering or reading of the Websites.

By agreeing to this hereto, the Interested Party confirms that
(i) It has read, understood and accepted this Information and the Disclaimer;
(ii) It informed itself about any possible legal restriction and warrants that it is not restricted or prohibited to enter the Websites according to any law applicable; and
(iii) It does not make available the contents of the Websites to any person who is not qualified by law to enter the Websites.